Investing Profile

Doug Cole

VCInvestor

Managing Partner at Flagship Pioneering

flagshippioneering.com/people...Cambridge, Massachusetts
Photo of Doug Cole, Managing Partner at Flagship Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Dartmouth College Network
48 CONNECTIONS
cb
Flagship Ventures Managing Partner
$100K - $5.0M
$1.5M
10
$824M
CompanyStageDateRound SizeTotal Raised
Repertoire Immune Medicines
Series BApr 2021$189M
Series ANov 2017$25M
$214M
Co-investors: Katie Ellias (T1D Fund)
Sigilon Therapeutics
Series BMar 2020$80.3M
$80.3M
Foghorn Therapeutics
Venture RoundMar 2018$50M
$50M
YourBio Health
Series CNov 2016$10M
$10M
Selecta Biosciences
Series ESep 2015$38M
Private Equity RoundOct 2014$20M
$88.1M
Co-investors: Amir Nashat (Polaris Partners)
Editas Medicine
Series BAug 2015$120M
$120M
Co-investors: Boris Nikolic (Biomatics Capital Partners)
Denali Therapeutics
Series AMay 2015$217M
$217M
Co-investors: Stacie Weninger (F-Prime Capital Partners)
Syros Pharmaceuticals
Series BOct 2014$53M
$53M
General Partner Flagship VenturesPresent
Program Executive Vertex PharmaceuticalsPresent
Medical Director Cytotherapeutics, Inc.Present
Assistant in Neurology Massachusetts General HospitalPresent
Instructor in Neurology Harvard Medical SchoolPresent
Fellow in Neurology Massachusetts General HospitalPresent
Resident in Neurology Massachusetts General HospitalPresent
Intern in Internal Medicine, Osler Medical Service Johns Hopkins HospitalPresent
University of Pennsylvania School of Medicine Doctor of Medicine (M.D.)
Dartmouth College AB magna cum laude English